Know Cancer

or
forgot password


N/A
18 Years
90 Years
Not Enrolling
Both
Hepatocellular Carcinoma, Liver Disease

Thank you

Trial Information


Inclusion Criteria:



- Ability and willingness to provide written informed consent

- Must be between 18-90 years of age at the time of consent

- Ability to provide urine specimen at protocol-defined timepoints

- Must have treatment interventions planned that are directly related to liver disease
(excluding those assigned to group 3-Controls)

Exclusion Criteria:

- Suspected inability, e.g. unwillingness to comply with study procedures or
unwillingness to provide written consent

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Cross-Sectional

Authority:

United States: Institutional Review Board

Study ID:

Urinary Biomarkers 101423

NCT ID:

NCT01316679

Start Date:

March 2011

Completion Date:

April 2014

Related Keywords:

  • Hepatocellular Carcinoma
  • Liver Disease
  • HCC
  • Liver Disease without HCC
  • Carcinoma
  • Liver Diseases
  • Carcinoma, Hepatocellular

Name

Location